Prodigy Asset Management
SANA icon

Prodigy Asset Management’s Sana Biotechnology SANA Stock Holding History

Prodigy Asset Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$58.4K Hold
20,050
– – 0.02% 31
2026
Q2 		$70K Hold
20,050
– – 0.02% 29
2026
Q1 		$57.7K Buy
+20,050
New +$79K 0.02% 28

Other funds holding SANA

Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
VCM
Viewpoint Capital Management Seattle, Washington $214M AUM 18.61% 1-Year Est. Return
Hoey Investments
Hoey Investments Coatesville, Pennsylvania $851M AUM 28.55% 1-Year Est. Return
NBC Securities
NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Prodigy Asset Management's SANA Position: Q3 2026 in Review

Prodigy Asset Management held its Sana Biotechnology (SANA) position steady in Q3 2026 at 20,050 shares worth $58.4K. The position accounts for 0.02% of the portfolio, ranked #31.

Prodigy Asset Management first reported a position in SANA in Q1 2026 and has held it in 3 quarters since. The position peaked at $70K in Q2 2026. 34 funds tracked by Wall St. Rank hold SANA as of Q3 2026.

  • Prodigy Asset Management held 20,050 shares of Sana Biotechnology worth $58.4K as of Q3 2026.
  • Prodigy Asset Management left its Sana Biotechnology share count unchanged in Q3 2026.
  • Sana Biotechnology made up 0.02% of Prodigy Asset Management's portfolio in Q3 2026, its #31 holding.
  • Prodigy Asset Management first reported a position in Sana Biotechnology in Q1 2026 and has held it in 3 quarters since.
  • Prodigy Asset Management's Sana Biotechnology position peaked at $70K in Q2 2026.
  • 34 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.

Based on Prodigy Asset Management's 13F filing for Q3 2026, filed 28 Oct 2026.